Cargando…
A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects
As an important regulatory mechanism at the posttranscriptional level in metazoans, adenosine deaminase acting on RNA (ADAR)-induced A-to-I RNA editing modification of double-stranded RNA has been widely detected and reported. Editing may lead to non-synonymous amino acid mutations, RNA secondary st...
Autores principales: | Wang, Heming, Chen, Sinuo, Wei, Jiayi, Song, Guangqi, Zhao, Yicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905090/ https://www.ncbi.nlm.nih.gov/pubmed/33643923 http://dx.doi.org/10.3389/fonc.2020.632187 |
Ejemplares similares
Ejemplares similares
-
Systematically Characterizing A-to-I RNA Editing Neoantigens in Cancer
por: Zhou, Chi, et al.
Publicado: (2020) -
Baicalein Induces Apoptosis of Pancreatic Cancer Cells by Regulating the Expression of miR-139-3p and miR-196b-5p
por: Ma, Danhui, et al.
Publicado: (2021) -
Fucoidan Inhibits the Progression of Hepatocellular Carcinoma via Causing lncRNA LINC00261 Overexpression
por: Ma, Danhui, et al.
Publicado: (2021) -
Drug Repurposing by Tumor Tissue Editing
por: Lüke, Florian, et al.
Publicado: (2022) -
Genome-wide identification of A-to-I RNA editing events provides the functional implications in PDAC
por: Mei, Yue, et al.
Publicado: (2023)